Evidence map›Paper›PMID 25644871›Full record

ReviewBiochimica et biophysica acta2015

S. Typhimurium strategies to resist killing by cationic antimicrobial peptides.

Susana Matamouros, Samuel I Miller

Abstract readReview
In one paragraph

Review in Biochimica et biophysica acta, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed.

  1. Article
  2. Development of covalent inhibitors for bacterial histidine kinases.Chemical communications (Cambridge, England) · 2026
    Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Defense mechanisms ofFrontiers in antibiotics · 2024
    Review
  8. Article
  9. FromACS omega · 2023
    Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Foods (Basel, Switzerland) · 2021
    Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Susana MatamourosDepartments of Microbiology, University of Washington, Seattle, WA 98195, USA.
Samuel I MillerDepartments of Microbiology, University of Washington, Seattle, WA 98195, USA; Departments of Genome Sciences, University of Washington, Seattle, WA 98195, USA; Department of Medicine, University of Washington, Seattle, WA 98195, USA. Electronic address: millersi@uw.edu.

Funding

ROLE OF THE PHOP REGULON IN SALMONELLA VIRULENCER01AI030479 · NIAID · UNIVERSITY OF WASHINGTON · PI MILLER, SAMUEL I · 1991 to 2014
$5.3M
NIAID NIH HHS R01 AI030479NIAID NIH HHS R01AI030479
6 · The paper itself

Abstract

S. Typhimurium is a broad host range Gram-negative pathogen that must evade killing by host innate immune systems to colonize, replicate, cause disease, and be transmitted to other hosts. A major pathogenic strategy of Salmonellae is entrance, survival, and replication within eukaryotic cell phagocytic vacuoles. These phagocytic vacuoles and gastrointestinal mucosal surfaces contain multiple cationic antimicrobial peptides (CAMPs) which control invading bacteria. S. Typhimurium possesses several key mechanisms to resist killing by CAMPs which involve sensing CAMPs and membrane damage to activate signaling cascades that result in remodeling of the bacterial envelope to reduce its overall negative charge with an increase in hydrophobicity to decrease binding and effectiveness of CAMPs. Moreover Salmonellae have additional mechanisms to resist killing by CAMPs including an outer membrane protease which targets cationic peptides at the surface, and specific efflux pumps which protect the inner membrane from damage. This article is part of a Special Issue entitled: Bacterial Resistance to Antimicrobial Peptides.

Indexed as

Drug Resistance, BacterialAnimalsAnti-Bacterial AgentsAntimicrobial Cationic PeptidesBacterial ProteinsHost-Pathogen InteractionsHumansImmune EvasionImmunity, InnateMembrane FluidityMembrane Transport ProteinsMicrobial ViabilityO AntigensProteolysisSalmonella InfectionsSalmonella typhimuriumAnti-Bacterial AgentsAntimicrobial Cationic PeptidesBacterial ProteinsMembrane Transport ProteinsO AntigensLipid A modificationOuter-membrane remodelingPolymyxinResistance to cationic antimicrobial peptideSalmonella Typhimurium

Identifiers

PMID25644871
PMCPMC4520786

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.